COPD PrevalanceNCT00388232
Prevalence of COPD: First Epidemiological Data From a Large Region of Turkey
An observational study of COPD Prevalance, run by Inonu University.
Trial summary
The study was designed to obtain some baseline data on COPD in Malatya region of Turkey. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- COPD Prevalance
- How many people
- 1,200 participants
- Where
- No sites listed yet
- Study dates
- Start not givento not given
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Adult, Older adult
Who may be able to join
- All households over 18 were included in the study
Who cannot join
- Age <18 years
About this study
Official title: Inonu University, The Department of Pulmonary Medicine
The study was designed to obtain some baseline data on COPD in Malatya region of Turkey.
Read the detailed description
Sixty clusters from urban and rural regions were randomly selected. Ten and seven consecutive houses were included in the study from each urban and rural cluster respectively. A validated questionnaire on epidemiology of COPD was completed for each household over 18 by a pulmonary physician. Each subject performed the standard spirometric measurement and early bronchodilation testing.
- Conditions
- COPD Prevalance
- Keywords
- COPD, prevalence, smoke, biomass, occupational, Malatya, Turkey
- Medical subject headings
- Pulmonary Disease, Chronic Obstructive
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Oct 2006 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for COPD PrevalanceStudies of the same condition, open and under way.
- More trials run by Inonu UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Time perspective
- Other
- Enrolment
- 1,200 participants
Sponsor and investigators
- Lead sponsor
- Inonu University
- Sponsor type
- University, hospital or other
- Investigators
- Hakan Gunen, Associate Professor, Study chair, Inonu University Department of Pulmonary Medicine
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00388232
- Sponsor's protocol ID
- 1-Gunen
- Status last verified
- Oct 2006
- First submitted
- 13 Oct 2006
- Last updated
- 16 Oct 2006
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 16 Oct 2006. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Inonu University, The Department of Pulmonary Medicine
- ClinicalTrials.gov ID
- NCT00388232
- Acronym / sponsor ID
- 1-Gunen
- Conditions
- COPD Prevalance
- Keywords
- COPD, prevalence, smoke, biomass, occupational, Malatya, Turkey
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 1,200 participants
- Lead sponsor
- Inonu UniversityUniversity, hospital or other
- First posted
- 16 Oct 2006 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The study was designed to obtain some baseline data on COPD in Malatya region of Turkey.
Detailed description
Sixty clusters from urban and rural regions were randomly selected. Ten and seven consecutive houses were included in the study from each urban and rural cluster respectively. A validated questionnaire on epidemiology of COPD was completed for each household over 18 by a pulmonary physician. Each subject performed the standard spirometric measurement and early bronchodilation testing.
Study design
- Time perspective
- Other
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- All households over 18 were included in the study
Key exclusion criteria (1 listed)
- Age <18 years
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Not reported in the source record.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Oct 2006.
Related trials for COPD Prevalance
Enrolling by invitationObservational study
The Italian Registry of Patients With Chronic Obstructive Pulmonary Disease
COPD, COPD Exacerbation Acute
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Hakan Gunen, Associate Professor study chair
Inonu University Department of Pulmonary Medicine
Questions about this trial
What is this clinical trial studying?
An observational study of COPD Prevalance, run by Inonu University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 16 Oct 2006. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Oct 2006.